Article ; Online: Ibrutinib topical delivery for melanoma treatment: The effect of nanostructured lipid carriers' composition on the controlled drug skin deposition.
Colloids and surfaces. B, Biointerfaces
2024 Volume 237, Page(s) 113875
Abstract: Melanoma is responsible for more than 80% of deaths related to skin diseases. Ibrutinib (IBR), a Bruton's tyrosine kinase inhibitor, has been proposed to treat this type of tumor. However, its low solubility, extensive first-pass effect, and severe ... ...
| Abstract | Melanoma is responsible for more than 80% of deaths related to skin diseases. Ibrutinib (IBR), a Bruton's tyrosine kinase inhibitor, has been proposed to treat this type of tumor. However, its low solubility, extensive first-pass effect, and severe adverse reactions with systemic administration affect therapeutic success. This study proposes developing and comparing the performance of two compositions of nanostructured lipid carriers (NLCs) to load IBR for the topical management of melanomas in their early stages. Initially, the effectiveness of IBR on melanoma proliferation was evaluated in vitro, and the results confirmed that the drug reduces the viability of human melanoma cells by inducing apoptosis at a dose that does not compromise dermal cells. Preformulation tests were then conducted to characterize the physical compatibility between the drug and the selected components used in NLCs preparation. Sequentially, two lipid compositions were used to develop the NLCs. Formulations were then characterized and subjected to in vitro release and permeation tests on porcine skin. The NLCs containing oleic acid effectively controlled IBR release over 24 h compared to the NLCs composed of pomegranate seed oil. Furthermore, the nanoparticles acted as permeation enhancers, increasing the fluidity of the lipids in the stratum corneum, as determined by EPR spectroscopy, which stimulated the IBR penetration more profoundly into the skin. However, the NLCs composition also influenced the permeation promotion factor. Thus, these findings emphasize the importance of the composition of NLCs in controlling and increasing the skin penetration of IBR and pave the way for future advances in melanoma therapy. |
|---|---|
| MeSH term(s) | Animals ; Swine ; Humans ; Melanoma/drug therapy ; Drug Carriers/chemistry ; Skin ; Nanostructures/chemistry ; Nanoparticles/chemistry ; Lipids/chemistry ; Particle Size ; Adenine/analogs & derivatives ; Piperidines |
| Chemical Substances | ibrutinib (1X70OSD4VX) ; Drug Carriers ; Lipids ; Adenine (JAC85A2161) ; Piperidines |
| Language | English |
| Publishing date | 2024-03-22 |
| Publishing country | Netherlands |
| Document type | Journal Article |
| ZDB-ID | 1500523-9 |
| ISSN | 1873-4367 ; 0927-7765 |
| ISSN (online) | 1873-4367 |
| ISSN | 0927-7765 |
| DOI | 10.1016/j.colsurfb.2024.113875 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.